(Q52626351)

4 May 2018

meta-analysis

0 references

title

Smoking quantity determines disease activity and function in Chinese patients with ankylosing spondylitis. (English)

1 reference

4 May 2018

31

John D Reveille

1 reference

4 May 2018

Hui Zhang

1

1 reference

4 May 2018

Wei Wan

2

1 reference

4 May 2018

Jing Liu

3

1 reference

4 May 2018

Shengming Dai

4

1 reference

4 May 2018

Yaohong Zou

5

1 reference

4 May 2018

Qiaoxia Qian

6

1 reference

4 May 2018

Yue Ding

7

1 reference

4 May 2018

Xia Xu

8

1 reference

4 May 2018

Hengdong Ji

9

1 reference

4 May 2018

Hongjun He

10

1 reference

4 May 2018

Qi Zhu

11

1 reference

4 May 2018

Chengde Yang

12

1 reference

4 May 2018

Shuang Ye

13

1 reference

4 May 2018

Lindi Jiang

14

1 reference

4 May 2018

Jianping Tang

15

1 reference

4 May 2018

Qiang Tong

16

1 reference

4 May 2018

Dongyi He

17

1 reference

4 May 2018

Dongbao Zhao

18

1 reference

4 May 2018

Yuan Li

19

1 reference

4 May 2018

Yanyun Ma

20

1 reference

4 May 2018

Jingru Zhou

21

1 reference

4 May 2018

Zhendong Mei

22

1 reference

4 May 2018

Xiangxiang Chen

23

1 reference

4 May 2018

Ziyu Yuan

24

1 reference

4 May 2018

Juan Zhang

25

1 reference

4 May 2018

Xiaofeng Wang

26

1 reference

4 May 2018

Yajun Yang

27

1 reference

4 May 2018

Li Jin

28

1 reference

4 May 2018

Ying Gao

29

1 reference

4 May 2018

Xiaodong Zhou

30

1 reference

4 May 2018

Hejian Zou

32

1 reference

4 May 2018

Jiucun Wang

33

1 reference

4 May 2018

publication date

27 March 2018

1 reference

4 May 2018

published in

Clinical Rheumatology

1 reference

4 May 2018

Characteristics of heavy smokers

cites work

1 reference

12 December 2020

Meta-analysis in clinical trials

1 reference

12 December 2020

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria

1 reference

12 December 2020

Ankylosing spondylitis: clinical course in women and men.

1 reference

12 December 2020

A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index

1 reference

12 December 2020

A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index

1 reference

12 December 2020

Operating characteristics of a rank correlation test for publication bias

1 reference

12 December 2020

Rheumatic diseases in China: ILAR-China study comparing the prevalence of rheumatic symptoms in northern and southern rural populations

1 reference

12 December 2020

The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis

1 reference

12 December 2020

Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis

1 reference

12 December 2020

Quantifying heterogeneity in a meta-analysis

1 reference

12 December 2020

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

12 December 2020

Prevalence of rheumatic symptoms, rheumatoid arthritis, ankylosing spondylitis, and gout in Shanghai, China: a COPCORD study

1 reference

12 December 2020

Evaluation of clinical activity and functional impairment in smokers with ankylosing spondylitis

1 reference

12 December 2020

Low prevalence of knee and back pain in southeast China; the Shantou COPCORD study.

1 reference

12 December 2020

Risk factors for functional limitations in patients with long-standing ankylosing spondylitis

1 reference

12 December 2020

Does cigarette smoking influence disease expression, activity and severity in early rheumatoid arthritis patients?

1 reference

12 December 2020

A systematic review identifies a lack of standardization in methods for handling missing variance data

1 reference

12 December 2020

Ankylosing spondylitis: an Australian experience

1 reference

12 December 2020

Prevalence survey of rheumatoid arthritis and spondyloarthropathy in Lithuania

1 reference

12 December 2020

Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial

1 reference

12 December 2020

An epidemiological survey of low back pain and axial spondyloarthritis in a Chinese Han population

1 reference

12 December 2020

Maintained clinical response of infliximab treatment in ankylosing spondylitis: a 6-year long-term study

1 reference

12 December 2020

-383 A/C tumor necrosis factor receptor 1 polymorphism and ankylosing spondylitis in Mexicans: a preliminary study.

1 reference

12 December 2020

Relationship between smoking and patient-reported measures of disease outcome in ankylosing spondylitis.

1 reference

12 December 2020

Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR cohort.

1 reference

12 December 2020

Association of cigarette smoking with Chinese ankylosing spondylitis patients in Taiwan: a poor disease outcome in systemic inflammation, functional ability, and physical mobility.

1 reference

12 December 2020

Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trial.

1 reference

12 December 2020

Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years

1 reference

12 December 2020

Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study.

1 reference

12 December 2020

Associations of smoking and alcohol consumption with disease activity and functional status in rheumatoid arthritis

1 reference

12 December 2020

Global prevalence of ankylosing spondylitis

1 reference

12 December 2020

Association study of genes related to bone formation and resorption and the extent of radiographic change in ankylosing spondylitis

1 reference

12 December 2020

Bone morphogenetic protein 6 polymorphisms are associated with radiographic progression in ankylosing spondylitis.

1 reference

12 December 2020

Current smoking is associated with incident ankylosing spondylitis -- the HUNT population-based Norwegian health study

1 reference

12 December 2020

Smoking did not modify the effects of anti-TNF treatment on health-related quality of life among Australian ankylosing spondylitis patients.

1 reference

12 December 2020

Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab

1 reference

12 December 2020

The effect of smoking on clinical and radiographic variables, and acute phase reactants in patients with ankylosing spondylitis

1 reference

12 December 2020

Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis: a longitudinal analysis

1 reference

12 December 2020

Effect of cigarette smoking and alcohol consumption on disease activity and physical functioning in ankylosing spondylitis: a cross-sectional study

1 reference

12 December 2020

Impact of tobacco smoking on response to tumour necrosis factor-alpha inhibitor treatment in patients with ankylosing spondylitis: results from the Danish nationwide DANBIO registry

1 reference

12 December 2020

10.1007/S10067-018-4016-3

Identifiers

DOI

1 reference

4 May 2018

PubMed ID

29589132

1 reference

4 May 2018